Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
Chapter 3 Market Overview and Definitions
- Overview: Autoimmune Disease Diagnostics
- Enzyme-|Linked Immunosorbent Assay (ELISA)
- Indirect Immunofluorescence (IIF)
- Multiplex Immunoassays
- Western Blot (Immunoblot)
- Other Technologies
- Indications
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Psoriatic Arthritis
- Multiple Sclerosis
- Inflammatory Bowel Disease
- The Global Regulatory Structure for Autoimmune Disease Diagnostics
- Test Validation
- FDA Clearance or Approval
- Good Manufacturing Practices (GMP)
- Labeling and Instructions
- Post-Market Surveillance
- Quality Control and Quality Assurance
- Clinical Utility and Medical Guidelines
- Privacy and Data Security
- Regulatory Scenario
- North American Regulations
- Latin American Regulations
- Asia-Pacific Regulations
Chapter 4 Market Dynamics
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Chapter 5 Market Breakdown by Region
- Market Overview and Discussion
- North America
- Mexico
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia and New Zealand
- Rest of Asia-Pacific
- Rest of the World
Chapter 6 Market Breakdown by Gender
- Market Overview and Discussion
- Male
- Female
- North American Market by Gender
- European Market by Gender
- Asia-Pacific Market by Gender
- Rest of the World Market by Gender
Chapter 7 Market Breakdown by Indication
- Market Overview and Discussion
- Type 1 Diabetes
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Psoriasis/Psoriatic Arthritis
- Multiple Sclerosis
- Inflammatory Bowel Disease
- Other Indications
Chapter 8 Market Breakdown by Technology
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Regional Markets
- Indirect Immunofluorescence (IIF)
- Regional Markets
- Immunoblot
- Regional Markets
- Multiplex Immunoassays
- Regional Markets
- Others
- Regional Markets
Chapter 9 ESG Development
- Introduction
- Environment
- Research Practices
- Supply Chain Sustainability
- Waste Management
- Energy Efficiency
- Social
- Access to Healthcare
- Patient Well-Being
- Community Engagement
- Governance
- Ethical Business Practices
- Compliance with Regulations
- Board Diversity
- Transparency and Accountability
- Case Study
- Roche
- Sustainability at Roche
- Concluding Remarks
Chapter 10 Emerging Trends and Technologies
Chapter 11 Competitive Landscape
- Overview
- Industry Scenario
- Company Shares
Chapter 12 Patent Analysis
- Patent Analysis by Manufacturer
Chapter 13 Pipeline Analysis
Chapter 14 M&A and Venture Funding Outlook
Chapter 15 Company Profiles
- ABBOTT
- BD BIOSCIENCES
- BECKMAN COULTER INC.
- BIOMERIEUX
- BIO-RAD (ABD SEROTEC)
- F. HOFFMANN-LA ROCHE AG
- QUEST DIAGNOSTICS INC.
- SIEMENS HEALTHCARE
- THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table: Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2028
Table 1: Components of ELISA
Table 2: Process of ELISA
Table 3: Components of Immunofluorescence (IIF)
Table 4: Process of Immunofluorescence (IIF)
Table 5: Types of Agglutination Test
Table 6: Global Market for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 7: North American Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 8: European Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 9: Asia-Pacific Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 10: Rest of the World Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 11: Global Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 12: North American Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 13: European Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 14: Asia-Pacific Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 15: Rest of the World Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 16: Global Market for Autoimmune Disease Diagnostics, by Indication, Through 2028
Table 17: Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, Through 2028
Table 18: Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, Through 2028
Table 19: Global Market for Autoimmune Disease Diagnostics for SLE, by Region, Through 2028
Table 20: Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, Through 2028
Table 21: Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, Through 2028
Table 22: Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, Through 2028
Table 23: Global Market for Autoimmune Disease Diagnostics for Other Disease Indications, by Region, Through 2028
Table 24: Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2028
Table 25: Global Market for ELISA for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 26: Global Market for Indirect Immunofluorescence (IIF) for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 27: Global Market for Immunoblot for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 28: Global Market for Multiplex Immunoassays for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 29: Global Market for Other Technologies for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 30: ESG Frameworks for the Global Autoimmune Disease Diagnostics Market
Table 31: Environmental (E) Factors in Autoimmune Disease Diagnostics
Table 32: Social Framework, Global Autoimmune Disease Diagnostics
Table 33: Social (S) Factors in Autoimmune Disease Diagnostics
Table 34: Governance (G) Factors in Autoimmune Disease Diagnostics
Table 35: Top Pharma Companies, ESG Ratings, 2022
Table 36: Sustainability at Roche, 2022
Table 37: Roche's Ten-Year Ambitions
Table 38: Global Autoimmune Disease Diagnostics Emerging Trends and Technologies
Table 39: Global Company Market Shares of Autoimmune Disease Diagnostics, 2022
Table 40: Patents on ELISA, 2018-Present
Table 41: Selected Manufacturer Patents on ELISA, 2018-Present
Table 42: Patents on Indirect Immunofluorescence, 2018-Present
Table 43: Selected Manufacturer Patents on Indirect Immunofluorescence, 2018-Present
Table 44: Patents on Western Blot, 2018-Present
Table 45: Selected Manufacturer Patents on Western Blot, 2018-Present
Table 46: Clinical Trials on Type 1 Diabetes Diagnostics, as of 2023
Table 47: Clinical Trials on Rheumatoid Arthritis Diagnostics, as of 2023
Table 48: Clinical Trials on Systemic Lupus Erythematosus Diagnostics, as of 2023
Table 49: Clinical Trials on Psoriasis Diagnostics, as of 2023
Table 50: Clinical Trials on Multiple Sclerosis Diagnostics, as of 2023
Table 51: Clinical Trials on Inflammatory Bowel Disease Diagnostics, as of 2023
Table 52: Global Autoimmune Disease Diagnostics Market: Mergers and Acquisitions, 2023
Table 53: Abbott: Product Information
Table 54: Abbott: Revenue, 2020-2022
Table 55: BD Biosciences: Product Information
Table 56: BD Biosciences: Revenue, 2020-2022
Table 57: Beckman Coulter Inc. (Danaher): Product Portfolio
Table 58: Danaher: Revenue, 2020-2022
Table 59: BioMérieux: Product Portfolio
Table 60: BioMérieux: Revenue, 2020-2022
Table 61: Bio-Rad: Product Portfolio
Table 62: Bio-Rad: Revenue, 2020-2022
Table 63: F. Hoffmann-La Roche AG: Product Portfolio
Table 64: F. Hoffmann-La Roche AG: Revenue, 2020-2022
Table 65: Quest Diagnostics: Revenue, 2020-2022
Table 66: Siemens Healthcare: Product Portfolio
Table 67: Siemens Healthcare: Revenue, 2020-2022
Table 68: Thermo Fisher Scientific: Product Portfolio
Table 69: Thermo Fisher Scientific: Revenue, 2020-2022
Table 70: Major Acronyms Used in This Report
List of Figures
Summary Figure: Global Market Shares of Autoimmune Disease Diagnostics, by Technology Type, 2022
Figure 1: Enzyme-Linked Immunosorbent Assay (ELISA)
Figure 2: Indirect Immunofluorescence (IIF)
Figure 3: Western Blot (Immunoblot)
Figure 4: Rheumatoid Arthritis
Figure 5: SLE
Figure 6: Global Market Shares of Autoimmune Disease Diagnostics, by Region, 2022
Figure 7: North American Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 8: European Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 9: Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 10: Global Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 11: North American Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 12: European Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 13: Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 14: Rest of the World Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 15: Global Market Shares of Autoimmune Disease Diagnostics, by Indication, 2022
Figure 16: Global Market Shares of Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, 2022
Figure 17: Global Market Shares of Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, 2022
Figure 18: Global Market Shares of Autoimmune Disease Diagnostics for SLE, by Region, 2022
Figure 19: Global Market Shares of Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, 2022
Figure 20: Global Market Shares of Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, 2022
Figure 21: Global Market Shares of Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, 2022
Figure 22: Global Market Shares of Autoimmune Disease Diagnostics for Other Disease Indications, by Region, 2022
Figure 23: Global Market Shares of Autoimmune Disease Diagnostics, by Technology, 2022
Figure 24: Global Electricity Produced from Renewable Sources, 2017-2021
Figure 25: Global Recycled Waste, 2017-2021
Figure 26: Global CO2 Emissions, 2017-2021
Figure 27: Global Company Market Shares of Autoimmune Disease Diagnostics, 2022
